Research & analysis only — not investment advice
Opening stock page...
Fetching company snapshot, pricing, and intelligence.
US equity research on AlphaOS
enGene Therapeutics Inc. operates in unknown sector.
enGene Therapeutics Inc. key market context on AlphaOS includes Market capitalization: $110.20M; Recent price: $1.65. Figures update as market data and SEC filings are ingested.
Use this ENGN research hub for earnings transcripts, SEC filings, opportunity scoring, news, and knowledge-graph relationships. Content is for research and education only — not investment advice.
Interactive charts, filings, and live quotes load below. Research & analysis only — not investment advice.
Intelligence coverage: 55%
Basic profile, financials, and market data are shown below. Deep research is building in the background.
AI confidence 50% · prior close shown (market closed)
Investment snapshot
Prior close
$1.65
Market cap
$110.20M
Profitable
No
Net income
$-117.30M
FY Oct 31, 2025
Loading Wall Street consensus…
Loading earnings intelligence…
Not enough price history yet — sync market data to compute EMA, RSI, support/resistance, and trend.
No price history. Sync market data to load charts.
Loading SEC filing intelligence…
No filings ingested yet.